M Christgen

Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer

Jochen Gaedcke, Frank Traub, Simone Milde et al. · Modern Pathology · 2007 · 146 citations · Full text

Medicine, Oncology, Pathology +17

ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer

Gaia Griguolo, Fara Brasó‐Maristany, Blanca González‐Farré et al. · Cancers · 2020 · 56 citations · Full text

Medicine, Cancer Biology, Oncology +17

TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy

M. Martín, S.R. Stecklein, Oleg Gluz et al. · Annals of Oncology · 2024 · 27 citations · Full text

Medicine, Bioinformatics, Oncology +16

189O Ribociclib + endocrine treatment vs SoC chemotherapy in intermediate risk HR+/HER2- early breast cancer: Results from the neoadjuvant cohort of the phase-III WSG ADAPTcycle – trial

N. Harbeck, Oleg Gluz, M Christgen et al. · ESMO Open · 2025 · 10 citations · Full text

Medicine, Endocrinology, Oncology +17